medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2016, Number 3

<< Back Next >>

Arch Inv Mat Inf 2016; 8 (3)

Efficacy of topical treatment with interferon alfa-2b for the treatment of squamous carcinoma of the ocular surface. Case report

De la Campa JJA, O’Shea CGJ

Language: Spanish
References: 23
Page: 85-88
PDF size: 559.90 Kb.


ABSTRACT

We present a case of a patient with connective-corneal intraepithelial neoplasia managed with interferon alpha-2b (IFN α-2b) topical. The conjunctival-corneal intraepithelial neoplasia (CIN) is the most frequent tumor of the ocular surface. There are several risk factors associated with the appearance of this lesion. Other therapeutic options are classic surgical treatment and adjuvant therapies with mitomycin C and 5 fluorouracil (5-FU).


REFERENCES

  1. Gómez-Cabrera CG, Cabrera-Arias JG, Sosa-Palacios O, Ramírez-García LK, Vigoa-Aranguren L. Caracterización epidemiológica de la neoplasia intraepitelial de la conjuntiva en el Instituto Cubano de Oftalmología “Ramón Pando Ferrer”, Rev Cubana Oftalmol, 2014; 27 (1): 100-108.

  2. Mittal R, Rath S, Vemuganti GK. Ocular surface squamous neoplasia - Review of etio-pathogenesis and an update on clinico-pathological diagnosis, Saudi J Ophthalmol, 2013; 27 (3): 177-186.

  3. Hanson RJ, Rubinstein A, Sarangapani S, Benjamin L, Patel CK. Effect of lens epithelial cell aspiration on postoperative capsulorhexis contraction with the use of the AcrySof intraocular lens: randomized clinical trial, J Cataract Refract Surg, 2006; 32 (10): 1621-1626.

  4. McDonnell PJ, Zarbin MA, Green WR. Posterior capsule opacification in pseudophakic eyes, Ophthalmology, 1983; 90 (12): 1548-1553.

  5. Tadros A, Bhatt UK, Abdul-Karim MN, Zaheer A, Thomas PW. Removal of lens epithelial cells and the effect on capsulorhexis size, J Cataract Refract Surg, 2005; 31 (8): 1569-1574.

  6. Davison JA. Capsule contraction syndrome, J Cataract Refract Surg, 1993; 19 (5): 582-589.

  7. Davison JA. Capsular bag distension after endophacoemulsification and posterior chamber intraocular lens implantation, J Cataract Refract Surg, 1990; 16 (1): 99-108.

  8. Hansen SO, Crandall AS, Olson RJ. Progressive constriction of the anterior capsular opening following intact capsulorhexis, J Cataract Refract Surg, 1993; 19 (1): 77-82.

  9. Nishi O, Nishi K. Intraocular lens encapsulation by shrinkage of the capsulorhexis opening, J Cataract Refract Surg, 1993; 19 (4): 544-545.

  10. Sacu S, Menapace R, Buehl W, Rainer G, Findl O. Effect of intraocular lens optic edge design and material on fibrotic capsule opacification and capsulorhexis contraction, J Cataract Refract Surg, 2004; 30 (9): 1875-1882.

  11. Moreno-Montañés J, Sánchez-Tocino H, Rodriguez-Conde R. Complete anterior capsule contraction after phacoemulsification with acrylic intraocular lens and endocapsular ring implantation, J Cataract Refract Surg, 2002; 28 (4): 717-719.

  12. Prinz A, Neumayer T, Buehl W, Vock L, Menapace R, Findl O et al. Rotational stability and posterior capsule opacification of a plate-haptic and an open-loop-haptic intraocular lens, J Cataract Refract Surg, 2011; 37 (2): 251-257.

  13. Saldanha MJ, Benjamin L, Patel CK. Postoperative rotation of a 3-piece loop-haptic acrylic intraocular lens, J Cataract Refract Surg, 2009; 35 (10): 1751-1755.

  14. Ohmi S. Decentration associated with asymmetric capsular shrinkage and intraocular lens size, J Cataract Refract Surg, 1993; 19 (5): 640-643.

  15. Strenn K, Menapace R, Vass C. Capsular bag shrinkage after implantation of an open-loop silicone lens and a poly(methyl methacrylate) capsule tension ring, J Cataract Refract Surg, 1997; 23 (10): 1543-1547.

  16. Chang DF. Comparative rotational stability of single-piece open-loop acrylic and plate-haptic silicone toric intraocular lenses, J Cataract Refract Surg, 2008; 34 (11): 1842-1847.

  17. Pérez de Arcelus M, Aranguren M, Andonegui J. Interferón alfa-2b tópico como primera opción en las neoplasias intraepiteliales corneoconjuntivales, Anales Sis San Navarra, 2012; 35 (1): 137-141.

  18. Toledano-Fernández N, García-Sáenz S, Díaz-Valle D, Arteaga-Sánchez A, Segura-Bedmar M, Lorenzo-Giménez S et al. Interferon alfa-2b treatment in selected cases of recurrent conjunctival intraepithelial neoplasia, Arch Soc Esp Oftalmol, 2003; 78 (5): 265-271.

  19. Mata E, Conesa E, Castro M, Martínez L, de Pablo C, González ML. Conjunctival squamous cell carcinoma: paradoxical response to interferon eyedrops, Arch Soc Esp Oftalmol, 2014; 89 (7): 293-296.

  20. Kusumesh R, Ambastha A, Sinha B, Kumar R. Topical interferon α-2b as a single therapy for primary ocular surface squamous neoplasia, Asia Pac J Ophthalmol (Phila), 2015; 4 (5): 279-282.

  21. Lezcano-Carduz VP, Mingo-Botín D, Durán-Poveda SP. Squamous cell neoplasm of the ocular surface in a patient with psoriasis treated with tumor necrosis factor-alpha inhibitors, Cornea, 2015; 34 (7): 833-834.

  22. Muñoz de Escalona Rojas JE, García-Serrano JL, Cantero-Hinojosa J, Padilla-Torres JF, Bellido-Muñoz RM. Application of interferon alpha 2b in conjunctival intraepithelial neoplasia: predictors and prognostic factors, J Ocul Pharmacol Ther, 2014; 30 (6): 489-494.

  23. Nanji AA, Moon CS, Galor A, Sein J, Oellers P, Karp CL. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications, Ophthalmology, 2014; 121 (5): 994-1000.




2020     |     www.medigraphic.com